Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996.
about
On the Use of Fractional Polynomial Models to Assess Preventive Aspect of Variables: An Example in Prevention of Mortality Following HIV InfectionEndosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Migration patterns among Floridians with AIDS, 1993-2007: implications for HIV prevention and careAdverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism.A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity.Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.HIV prevention in the era of new treatments.Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of DissentRural AIDS diagnoses in Florida: changing demographics and factors associated with survival.Atazanavir: its role in HIV treatmentNon-proteolytic functions of microbial proteases increase pathological complexity.Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice.Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase.Indinavir impairs protein synthesis and phosphorylations of MAPKs in mouse C2C12 myocytes.People fifty years or older now account for the majority of AIDS cases in San Francisco, California, 2010.Community poverty and trends in racial/ethnic survival disparities among people diagnosed with AIDS in Florida, 1993-2004
P2860
Q28704413-3084B1B5-7511-4626-B4D7-FFF9DB6F246BQ34059457-44EA49B9-CD7C-4DA7-81C6-3E02188F6B03Q34138241-CDC98420-33B8-48D5-B2B0-79BB9742FE3CQ34187120-5D940067-E498-4509-A616-38FD8C24A4A3Q34455618-56EE7BD5-68B4-4937-8EB2-AAF13EA3C18CQ34620836-B0B62E58-2CB9-4933-9A5B-C4C2188664B5Q35581199-59E77454-0114-4D43-8259-058324F6F7DDQ35925705-B23DB652-7900-4A58-BCEB-529F4527D9ADQ36962851-C7B2026C-3EDC-461C-AE19-225E750DBB13Q37249418-CCF34FC8-05A9-4F74-9F00-3810CC0F9F24Q38285969-22EDA503-8A6E-4B74-8D1C-117B6EDD919BQ40756790-2B39336B-DC0F-43AF-973C-EF839680FCB4Q41920342-1BF18E37-7C70-42E5-A818-86F75A93FCDEQ42464012-459DBCF3-3654-4F52-B8EF-D50BD01BADBBQ45331103-B8215927-40C4-4328-8F8A-D2D976E565D9Q58856106-81B6DA5A-B170-4BE3-87D5-FAB1774240D8
P2860
Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@ast
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@en
type
label
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@ast
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@en
prefLabel
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@ast
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@en
P2093
P921
P356
P1476
Impact of protease inhibitors ...... ncisco, California, 1987-1996.
@en
P2093
P304
P356
10.1093/AJE/152.2.178
P407
P577
2000-07-01T00:00:00Z